title: Resolvin D2 restores neutrophil directionality and improves survival after burns.
abstract: Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double-edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil-induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double-injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8-10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2-treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.
authors: Shriners Hospital for Children, Boston, Massachuestts, USA.
authors: Tomohiro
authors: T
authors: Kurihara
authors: Caroline N
authors: CN
authors: Jones
authors: Yong-Ming
authors: YM
authors: Yu
authors: Alan J
authors: AJ
authors: Fischman
authors: Susumu
authors: S
authors: Watada
authors: Ronald G
authors: RG
authors: Tompkins
authors: Shawn P
authors: SP
authors: Fagan
authors: Daniel
authors: D
authors: Irimia
mesh_terms: D000818:Animals; D002056:Burns / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology; D004281:Docosahexaenoic Acids / Q000494:pharmacology* / Q000502:physiology; D008297:Male; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D018805:Sepsis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology
chemical_list: C518399:resolvin D1; C545423:resolvin D2; D004281:Docosahexaenoic Acids
keywords: chemotaxis; inflammation; innate immunity; lipid mediators; microfluidics